[1] 范建高,李锋,蔡晓波,等. 1995至2002年上海宝钢职工队列人群脂肪肝患病率变化.肝脏,2006,11(3):154-157. [2] Rafiq N,Bai C,Fang Y,et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol,2009,7(2):234-238. [3] 范建高.脂肪肝促发代谢紊乱和动脉硬化的机制.诊断学理论与实践,2007,6(2):108-110. [4] Anstee QM,Targher G,Day CP. Progression of NAFLD to diabetes mellitus,cardiovascular disease or cirrhosis.Nat Rev Gastroenterol Hepatol,2013,10(6):330-344. [5] Willum-Hansen T,Staessen JA,Torp-Pedersen C,et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population.Circulation,2006,113(5):664-670. [6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南(2010年修订版).中华肝脏病杂志,2010,18(3):167-170. [7] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).中华肝脏病杂志,2010,18(3):163-166. [8] 胡大一. 心血管疾病防治指南和共识2008. 北京:人民卫生出版社,2008:37-43. [9] Vlachopoulos C,Aznaouridis K,Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol,2010,55(13):1318-1327. [10] Elsheikh E,Younoszai Z,Otgonsuren M,et al. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease. J Gastroenterol Hepatol,2014,29(7):1528-1534. [11] Cohn JN. Arteries, myocardium, blood pressure and cardiovascular risk:towards a revised definition of hypertension.J Hypertens,1998,16(12Pt2):2117-2124. [12] Lavi S,Bae JH,Rihal CS,et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart,2009,95(18):1525-1530. [13] Villanova N,Moscatiello S,Ramilli S,et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology,2005,42(2):473-480. [14] Targher G,Bertolini L,Padovani R,et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care,2006,29(6):1325-1330. [15] 曹一显,李良平.非酒精性脂肪性肝炎与内皮功能异常和动脉粥样硬化的关系.中华肝脏病杂志,2014,22(3):205-208. [16] Sookoian S,Castano GO,Burgueno AL,et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.Atherosclerosis,2010,209(2):585-591. [17] 徐瑞霞,李建军.氧化型低密度脂蛋白胆固醇与动脉粥样硬化.中国医学前沿杂志(电子版),2012,4(8):33-37. [18] Marinou K,Adiels M,Hodson L,et al. Young women partition fatty acids towards ketone body production rather than VLDL-TAG synthesis,compared with young men.Br J Nutr,2011,105(6):857-865. [19] Kim BJ,Kim NH,Kim BS,et al. The association between nonalcoholic fatty liver disease,metabolic syndrome and arterial stiffness in nondiabetic,nonhypertensive individuals. Cardiology,2012,123(1):54-61. [20] Zhu WH,Fang LZ,Lu CR,et al. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity. World J Gastroenterol,2015,21(35):10192-10199. [21] 施军平,范建高. 2009年非酒精性脂肪性肝病临床研究进展回顾. 实用肝脏病杂志,2010,13(1):1-3,15. [22] 林光宇,林金秀. 高血压患者各节段动脉弹性功能的相关性及影响因素分析. 临床心血管病杂志,2011,27(8):577-582. [23] 范建高,潘勤. 加强高脂血症脂肪肝的基础和临床研究.实用肝脏病杂志,2011,14(4):241-242. |